305 related articles for article (PubMed ID: 15739081)
1. Clinical and molecular prognostic factors in operable laryngeal cancer.
Vlachtsis K; Nikolaou A; Markou K; Fountzilas G; Daniilidis I
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):890-8. PubMed ID: 15739081
[TBL] [Abstract][Full Text] [Related]
2. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
3. [Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].
Almadori G; Cadoni G; Maurizi M; Ottaviani F; Paludetti G; Cattani P; Scambia G
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1 Suppl 46):1-22. PubMed ID: 7793243
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical demonstration of multiple HPV types in laryngeal squamous cell carcinoma.
Morshed K; Korobowicz E; Szymański M; Skomra D; Gołabek W
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):917-20. PubMed ID: 15924277
[TBL] [Abstract][Full Text] [Related]
6. [Survivin expression in laryngeal squamous cell carcinoma and its relationship with clinical factors].
Chen YF; Chen FJ; Fang Y; Yang AK; Zhang Q; Wu GH
Ai Zheng; 2004 Nov; 23(11 Suppl):1493-7. PubMed ID: 15566665
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy.
Parikh RR; Yang Q; Haffty BG
Cancer; 2007 Feb; 109(3):566-73. PubMed ID: 17183558
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
Ahmed RA; Shawky Ael-A; Hamed RH
Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
[TBL] [Abstract][Full Text] [Related]
9. A correlation analysis between HDAC1 over-expression and clinical features of laryngeal squamous cell carcinoma.
Zhao R; Chen K; Cao J; Yu H; Tian L; Liu M
Acta Otolaryngol; 2016; 136(2):172-6. PubMed ID: 26588579
[TBL] [Abstract][Full Text] [Related]
10. Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.
Krikelis D; Kotoula V; Bobos M; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Vlachtsis K; Kalogeras KT; Nikolaou A; Fountzilas G
Anticancer Res; 2014 Nov; 34(11):6495-503. PubMed ID: 25368251
[TBL] [Abstract][Full Text] [Related]
11. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
12. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
Foteinou E; Kontos CK; Giotakis AI; Scorilas A
Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the expression of VEGF using qRT-PCR, evaluation of MVD and their correlation with clinicopathological factors in laryngeal squamous cell carcinoma.
Koçdor P; Coker I; Bayol U; Altınel D; Purcu DU; Kaptaner S; Yiğitbaşı OG
Kulak Burun Bogaz Ihtis Derg; 2011; 21(3):137-44. PubMed ID: 21595617
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the expression of hypoxia-inducible factor-1alpha and epidermal growth factor receptor and micro vessel density and their clinical significance].
Lin P; Wang W; Cai WJ; Han CR; Sun Y; Li M; Sun BC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 44(6):480-5. PubMed ID: 19954019
[TBL] [Abstract][Full Text] [Related]
15. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.
Liu Y; Su Z; Li G; Yu C; Ren S; Huang D; Fan S; Tian Y; Zhang X; Qiu Y
Int J Cancer; 2013 Aug; 133(3):671-9. PubMed ID: 23364922
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.
Georgiou A; Gomatos IP; Ferekidis E; Syrigos K; Bistola V; Giotakis J; Adamopoulos G; Androulakis G
Eur J Surg Oncol; 2001 Sep; 27(6):574-80. PubMed ID: 11520092
[TBL] [Abstract][Full Text] [Related]
18. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
19. [The expression and correlation of HMGB1 and VEGF protein in laryngeal squamous cell carcinoma].
Liu Y; Qiu Y; Zhang X; Tian Y; Huang D; Zhou X; Tan P; Yu C; Qi L; Xiao J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 25(6):265-9. PubMed ID: 21650061
[TBL] [Abstract][Full Text] [Related]
20. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
